Fibromyalgia: The diagnosis and pharmacologic treatment

Dan Buskila

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations


    Fibromyalgia (FM) is a chronic condition characterized by widespread pain and diffuse tenderness along with a constellation of ancillary symptoms. The 1990 ACR criteria for classification of FM are important in enhancing much the research of FM. FM is part of a spectrum of functional somatic syndromes. FM is not a homogenous condition and several subtypes of FM had been determined. The best strategy for management of FM is to use a multidisciplinary approach to treatment using both pharmacological and non-pharmacological interventions. Tramadol, tricyclic drugs, mixed reuptake inhibitors and anticonvulsants show efficacy in this condition. Recently, three drugs: pregabalin, duloxetine and milnacipran have been approved by the FDA for treatment of FM.

    Original languageEnglish
    Pages (from-to)111-115
    Number of pages5
    JournalEuropean Journal of Pain Supplements
    Issue number2
    StatePublished - 1 Nov 2009


    • Alpha 2 delta ligands
    • Chronic widespread pain
    • Fibromyalgia
    • Functional somatic syndromes
    • Pharmacologic treatment
    • Reuptake inhibitors

    ASJC Scopus subject areas

    • Anesthesiology and Pain Medicine


    Dive into the research topics of 'Fibromyalgia: The diagnosis and pharmacologic treatment'. Together they form a unique fingerprint.

    Cite this